AllianceBernstein’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $485K | Buy |
50,590
+5,000
| +11% | +$48K | ﹤0.01% | 2653 |
|
|
2025
Q1 | $286K | Hold |
45,590
| – | – | ﹤0.01% | 2794 |
|
|
2024
Q4 | $370K | Sell |
45,590
-4,520
| -9% | -$36.7K | ﹤0.01% | 2776 |
|
|
2024
Q3 | $906K | Hold |
50,110
| – | – | ﹤0.01% | 2370 |
|
|
2024
Q2 | $516K | Buy |
50,110
+17,820
| +55% | +$184K | ﹤0.01% | 2653 |
|
|
2024
Q1 | $343K | Sell |
32,290
-5,410
| -14% | -$57.5K | ﹤0.01% | 2758 |
|
|
2023
Q4 | $344K | Hold |
37,700
| – | – | ﹤0.01% | 2782 |
|
|
2023
Q3 | $391K | Hold |
37,700
| – | – | ﹤0.01% | 2689 |
|
|
2023
Q2 | $540K | Buy |
37,700
+10,400
| +38% | +$149K | ﹤0.01% | 2595 |
|
|
2023
Q1 | $195K | Buy |
27,300
+4,800
| +21% | +$34.3K | ﹤0.01% | 2914 |
|
|
2022
Q4 | $252K | Buy |
22,500
+6,700
| +42% | +$75.2K | ﹤0.01% | 2924 |
|
|
2022
Q3 | $175K | Buy |
15,800
+1,200
| +8% | +$13.3K | ﹤0.01% | 3041 |
|
|
2022
Q2 | $123K | Buy |
14,600
+2,900
| +25% | +$24.4K | ﹤0.01% | 3098 |
|
|
2022
Q1 | $159K | Sell |
11,700
-1,200
| -9% | -$16.3K | ﹤0.01% | 3030 |
|
|
2021
Q4 | $254K | Buy |
12,900
+1,900
| +17% | +$37.4K | ﹤0.01% | 2985 |
|
|
2021
Q3 | $353K | Sell |
11,000
-1,300
| -11% | -$41.7K | ﹤0.01% | 2895 |
|
|
2021
Q2 | $416K | Buy |
12,300
+1,800
| +17% | +$60.9K | ﹤0.01% | 2880 |
|
|
2021
Q1 | $394K | Sell |
10,500
-900
| -8% | -$33.8K | ﹤0.01% | 2765 |
|
|
2020
Q4 | $379K | Sell |
11,400
-700
| -6% | -$23.3K | ﹤0.01% | 2724 |
|
|
2020
Q3 | $444K | Sell |
12,100
-1,900
| -14% | -$69.7K | ﹤0.01% | 2574 |
|
|
2020
Q2 | $461K | Buy |
+14,000
| New | +$461K | ﹤0.01% | 2655 |
|